CytomX Therapeutics Announces FDA Clearance of Investigational N

CTMX: CytomX Therapeutics, Inc.
2022-01-19 08:00:00
CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors
Beyond Technical Analysis

Clause de non-responsabilité